Ngā hua rapu - Ilene Wiggins
- E whakaatu ana i te 1 - 3 hua o te 3
-
1
Safety, Tolerability, and Pharmacokinetic Interactions of the Antituberculous Agent TMC207 (Bedaquiline) With Efavirenz in Healthy Volunteers mā Kelly E. Dooley, Jeong-Gun Park, Susan Swindells, R. Allen, David W. Haas, Yoninah Cramer, Francesca Aweeka, Ilene Wiggins, Amita Gupta, Patricia Lizak, Sonia Qasba, Rolf van Heeswijk, Charles Flexner
I whakaputaina 2011Artigo -
2
Multiple-Dose Escalation Study of the Safety, Pharmacokinetics, and Biologic Activity of Oral AMD070, a Selective CXCR4 Receptor Inhibitor, in Human Subjects mā Nimalie D. Stone, Shelia B. Dunaway, Charles Flexner, Camlin Tierney, Gary Calandra, Stephen Becker, Ying-Jun Cao, Ilene Wiggins, Jeanne Conley, Ron MacFarland, Jeong-Gun Park, Christina M. Lalama, Sally Snyder, Beatrice Kallungal, Karin L. Klingman, Craig W. Hendrix
I whakaputaina 2007Artigo -
3
Dose Frequency Ranging Pharmacokinetic Study of Tenofovir-Emtricitabine After Directly Observed Dosing in Healthy Volunteers to Establish Adherence Benchmarks (HPTN 066) mā Craig W. Hendrix, Adriana Andrade, Namandjé N. Bumpus, Angela D. M. Kashuba, Mark A. Marzinke, Ayana Moore, Peter L. Anderson, Lane R. Bushman, Edward J. Fuchs, Ilene Wiggins, Christine Radebaugh, Heather A. Prince, Rahul P. Bakshi, Ruili Wang, Paul Richardson, Eugenie Shieh, Laura McKinstry, Xin Li, Deborah Donnell, Vanessa Elharrar, Kenneth H. Mayer, Kristine B. Patterson
I whakaputaina 2015Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Internal medicine
Medicine
Pharmacokinetics
Pharmacology
Adverse effect
Antiretroviral therapy
Area under the curve
Cmax
Human immunodeficiency virus (HIV)
Viral load
Bedaquiline
Biochemistry
Biology
CYP2B6
CYP3A4
Cmin
Culture conversion
Cytochrome P450
Dosing
Efavirenz
Emtricitabine
Gastroenterology
Immunology
In vitro
Leukocytosis
Men who have sex with men
Metabolism
Mycobacterium tuberculosis
Pathology
Peripheral blood mononuclear cell